Published in Microorganisms on May 13, 2017
Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev (2007) 3.61
S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci U S A (2008) 2.65
Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther (2007) 2.38
The role of short-chain fatty acids in health and disease. Adv Immunol (2014) 1.54
Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ (2002) 1.42
Survival and metabolic activity of selected strains of Propionibacterium freudenreichii in the gastrointestinal tract of human microbiota-associated rats. Br J Nutr (2007) 1.38
Biogenesis and functions of bacterial S-layers. Nat Rev Microbiol (2014) 1.32
Life under stress: the probiotic stress response and how it may be manipulated. Curr Pharm Des (2008) 1.31
The complete genome of Propionibacterium freudenreichii CIRM-BIA1, a hardy actinobacterium with food and probiotic applications. PLoS One (2010) 1.28
Isolation and identification of a new bifidogenic growth stimulator produced by Propionibacterium freudenreichii ET-3. Biosci Biotechnol Biochem (2002) 1.25
Conjugated linoleic acid isomers: differences in metabolism and biological effects. Biofactors (2009) 1.24
Staphylococcus aureus adheres to human intestinal mucus but can be displaced by certain lactic acid bacteria. Microbiology (2006) 1.21
Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells. Am J Physiol Gastrointest Liver Physiol (2012) 1.18
Mass spectrometry proteomic analysis of stress adaptation reveals both common and distinct response pathways in Propionibacterium freudenreichii. Arch Microbiol (2004) 1.17
Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Clin Exp Gastroenterol (2014) 1.17
Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese. Int J Food Microbiol (2010) 1.17
Ability of Lactobacillus and Propionibacterium strains to remove aflatoxin B, from the chicken duodenum. J Food Prot (2000) 1.14
New insights into physiology and metabolism of Propionibacterium freudenreichii. Int J Food Microbiol (2011) 1.12
Biological significance of short-chain fatty acid metabolism by the intestinal microbiome. Curr Opin Clin Nutr Metab Care (2014) 1.10
Susceptibility and adaptive response to bile salts in Propionibacterium freudenreichii: physiological and proteomic analysis. Appl Environ Microbiol (2003) 1.10
Gut microbiota-derived short-chain Fatty acids, T cells, and inflammation. Immune Netw (2014) 1.10
Production of conjugated linoleic acid by dairy starter cultures. J Appl Microbiol (1998) 1.10
Changes in protein synthesis and morphology during acid adaptation of Propionibacterium freudenreichii. Appl Environ Microbiol (2001) 1.09
Acidic extracellular pH shifts colorectal cancer cell death from apoptosis to necrosis upon exposure to propionate and acetate, major end-products of the human probiotic propionibacteria. Apoptosis (2006) 1.09
Promising immunomodulatory effects of selected strains of dairy propionibacteria as evidenced in vitro and in vivo. Appl Environ Microbiol (2010) 1.06
Human ileostomy glycoproteins as a model for small intestinal mucus to investigate adhesion of probiotics. Lett Appl Microbiol (1999) 1.03
Surface proteins of Propionibacterium freudenreichii are involved in its anti-inflammatory properties. J Proteomics (2014) 1.01
Transcarboxylase mRNA: a marker which evidences P. freudenreichii survival and metabolic activity during its transit in the human gut. Int J Food Microbiol (2006) 0.97
Adhesion of inactivated probiotic strains to intestinal mucus. Lett Appl Microbiol (2000) 0.96
The opportunistic pathogen Propionibacterium acnes: insights into typing, human disease, clonal diversification and CAMP factor evolution. PLoS One (2013) 0.96
Aflatoxin B1 binding by a mixture of Lactobacillus and Propionibacterium: in vitro versus ex vivo. J Food Prot (2005) 0.95
Conjugated Linoleic Acid: Potential Health Benefits as a Functional Food Ingredient. Annu Rev Food Sci Technol (2016) 0.95
Correlation of the capsular phenotype in Propionibacterium freudenreichii with the level of expression of gtf, a unique polysaccharide synthase-encoding gene. Appl Environ Microbiol (2010) 0.94
In vitro assessment of the upper gastrointestinal tolerance of potential probiotic dairy propionibacteria. Int J Food Microbiol (2004) 0.94
S-layer fusion proteins--construction principles and applications. Curr Opin Biotechnol (2011) 0.94
The genome sequence of Propionibacterium acidipropionici provides insights into its biotechnological and industrial potential. BMC Genomics (2012) 0.93
Growth stimulator for bifidobacteria produced by Propionibacterium freudenreichii and several intestinal bacteria. J Dairy Sci (1994) 0.93
Combining strains of lactic acid bacteria may reduce their toxin and heavy metal removal efficiency from aqueous solution. Lett Appl Microbiol (2007) 0.92
Increased induction of apoptosis by Propionibacterium freudenreichii TL133 in colonic mucosal crypts of human microbiota-associated rats treated with 1,2-dimethylhydrazine. Br J Nutr (2008) 0.92
The influence of Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon. Int J Food Microbiol (2008) 0.92
Milk fermented by Propionibacterium freudenreichii induces apoptosis of HGT-1 human gastric cancer cells. PLoS One (2012) 0.92
Changes in protein synthesis during thermal adaptation of Propionibacterium freudenreichii subsp. shermanii. Int J Food Microbiol (2006) 0.92
Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China. Am J Clin Nutr (2006) 0.91
SIGNR3-dependent immune regulation by Lactobacillus acidophilus surface layer protein A in colitis. EMBO J (2015) 0.90
Enhancement of trehalose production in dairy propionibacteria through manipulation of environmental conditions. Int J Food Microbiol (2004) 0.90
Conjugated linolenic acids and their bioactivities: a review. Food Funct (2014) 0.89
Paracrystalline surface layers of dairy propionibacteria. Appl Environ Microbiol (1993) 0.88
Identification of a probiotic bacteria-derived activator of the aryl hydrocarbon receptor that inhibits colitis. Immunol Cell Biol (2014) 0.88
The production of conjugated α-linolenic, γ-linolenic and stearidonic acids by strains of bifidobacteria and propionibacteria. Lipids (2011) 0.87
Contribution of surface β-glucan polysaccharide to physicochemical and immunomodulatory properties of Propionibacterium freudenreichii. Appl Environ Microbiol (2012) 0.87
Tracking the microbiome functionality: focus on Propionibacterium species. Gut (2013) 0.87
Production of vitamin B12 in genetically engineered Propionibacterium freudenreichii. J Biosci Bioeng (2004) 0.86
The first dairy product exclusively fermented by Propionibacterium freudenreichii: a new vector to study probiotic potentialities in vivo. Food Microbiol (2012) 0.86
Kinetics of adsorption and desorption of aflatoxin B1 by viable and nonviable bacteria. J Food Prot (2003) 0.86
1,4-Dihydroxy-2-naphthoic acid from Propionibacterium freudenreichii reduces inflammation in interleukin-10-deficient mice with colitis by suppressing macrophage-derived proinflammatory cytokines. J Leukoc Biol (2013) 0.86
Permanent draft genome sequence of the probiotic strain Propionibacterium freudenreichii CIRM-BIA 129 (ITG P20). Stand Genomic Sci (2016) 0.85
Probiotics, gut microbiota, and their influence on host health and disease. Mol Nutr Food Res (2016) 0.85
Bifidobacteria and Their Role as Members of the Human Gut Microbiota. Front Microbiol (2016) 0.84
Intestinal mucus alters the ability of probiotic bacteria to bind aflatoxin B1 in vitro. Appl Environ Microbiol (2004) 0.84
Assessment of the probiotic potential of a dairy product fermented by Propionibacterium freudenreichii in piglets. J Agric Food Chem (2012) 0.84
Mechanism of conjugated linoleic acid and vaccenic acid formation in human faecal suspensions and pure cultures of intestinal bacteria. Microbiology (2009) 0.84
Modulation of inflammation and immunity by dietary conjugated linoleic acid. Eur J Pharmacol (2015) 0.83
A unique in vivo experimental approach reveals metabolic adaptation of the probiotic Propionibacterium freudenreichii to the colon environment. BMC Genomics (2013) 0.83
Diet, microorganisms and their metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol (2016) 0.83
Systems-level understanding of how Propionibacterium acidipropionici respond to propionic acid stress at the microenvironment levels: mechanism and application. J Biotechnol (2013) 0.83
Understanding of how Propionibacterium acidipropionici respond to propionic acid stress at the level of proteomics. Sci Rep (2014) 0.82
Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease. Inflamm Bowel Dis (2015) 0.81
Interaction of Campylobacter spp. and human probiotics in chicken intestinal mucus. Zoonoses Public Health (2012) 0.80
Modulation of peroxisome proliferator-activated receptor gamma (PPAR γ) by conjugated fatty acid in obesity and inflammatory bowel disease. J Agric Food Chem (2015) 0.80
Bacterial production of conjugated linoleic and linolenic Acid in foods: a technological challenge. Crit Rev Food Sci Nutr (2015) 0.80
Conjugated linoleic acid content and organoleptic attributes of fermented milk products produced with probiotic bacteria. J Agric Food Chem (2005) 0.80
Great interspecies and intraspecies diversity of dairy propionibacteria in the production of cheese aroma compounds. Int J Food Microbiol (2014) 0.80
Combining selected immunomodulatory Propionibacterium freudenreichii and Lactobacillus delbrueckii strains: Reverse engineering development of an anti-inflammatory cheese. Mol Nutr Food Res (2015) 0.79
Aerobic culture of Propionibacterium freudenreichii ET-3 can increase production ratio of 1,4-dihydroxy-2-naphthoic acid to menaquinone. J Biosci Bioeng (2006) 0.79
Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer. Mol Nutr Food Res (2016) 0.79
Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clin Microbiol Rev (2017) 0.78
Emmental Cheese Environment Enhances Propionibacterium freudenreichii Stress Tolerance. PLoS One (2015) 0.78
Role of 2-amino-3-carboxy-1,4-naphthoquinone, a strong growth stimulator for bifidobacteria, as an electron transfer mediator for NAD(P)(+) regeneration in Bifidobacterium longum. Biochim Biophys Acta (1999) 0.78
Conjugated linoleic acid suppresses dendritic cell activation and subsequent Th17 responses. J Nutr Biochem (2014) 0.78
Some factors affecting the adherence of probiotic Propionibacterium acidipropionici CRL 1198 to intestinal epithelial cells. Can J Microbiol (2002) 0.77
Identification of proteins involved in the anti-inflammatory properties of Propionibacterium freudenreichii by means of a multi-strain study. Sci Rep (2017) 0.77
Reduction of linoleic acid inhibition in production of conjugated linoleic acid by Propionibacterium freudenreichii ssp. shermanii. Can J Microbiol (2001) 0.77
Bifidogenic growth stimulator for the treatment of active ulcerative colitis: a pilot study. Nutrition (2005) 0.77
Survival of lactic acid and propionibacteria in low- and full-fat Dutch-type cheese during human digestion ex vivo. Lett Appl Microbiol (2016) 0.76
Dairy bacteria remove in vitro dietary lectins with toxic effects on colonic cells. J Appl Microbiol (2009) 0.76
Potential influence of dairy propionibacteria on the growth and acid metabolism of Streptococcus bovis and Megasphaera elsdenii. Benef Microbes (2016) 0.76
Physiological and functional characteristics of Propionibacterium strains of the poultry microbiota and relevance for the development of probiotic products. Anaerobe (2013) 0.76
Improved propionic acid and 5,6-dimethylbenzimidazole control strategy for vitamin B12 fermentation by Propionibacterium freudenreichii. J Biotechnol (2014) 0.76
The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer. Oncotarget (2016) 0.76
Effect of Propionibacterium freudenreichii on Salmonella multiplication, motility, and association with avian epithelial cells. Poult Sci (2016) 0.76
Aggregation and hydrophobicity properties of 6 dairy propionibacteria strains isolated from homemade Turkish cheeses. J Food Sci (2011) 0.76
Newly antibacterial and antiadhesive lipopeptide biosurfactant secreted by a probiotic strain, Propionibacterium freudenreichii. Appl Biochem Biotechnol (2014) 0.76
Evidences and perspectives in the utilization of CLNA isomers as bioactive compounds in foods. Crit Rev Food Sci Nutr (2017) 0.76
Exploring the relationship between exposure to technological and gastrointestinal stress and probiotic functional properties of lactobacilli and bifidobacteria. Can J Microbiol (2016) 0.76
Sources and Bioactive Properties of Conjugated Dietary Fatty Acids. Lipids (2016) 0.76
Propionibacterium acidipropionici CRL1198 influences the production of acids and the growth of bacterial genera stimulated by inulin in a murine model of cecal slurries. Anaerobe (2010) 0.76
Inhibition of enteropathogens adhesion to human enterocyte-like HT-29 cells by a dairy strain of Propionibacterium acidipropionici. Benef Microbes (2016) 0.75